Antibody Testing Market is expected to reach US$ 11,578.47 million by 2028

Antibody Testing Market for Kits Segment to Grow at Highest CAGR during 2021–2028

According to our new market research study on “Antibody Testing Market to 2028 – Global Analysis and Forecast – by vaccine type and route of administration,” the global antibody testing market is expected to grow from US$ 7,260.00 million in 2021 to US$ 11,578.47 million by 2028. The global antibody testing market is estimated to grow with a CAGR of 6.9% from 2021 to 2028. The report highlights trends prevailing in the market, and drivers and hindrances pertaining to the market growth.

Based on products, the market is segmented into kits, chemical & reagents, and consumables. In 2021, the kits segment accounted for the highest share of the market. The growth of this segment is attributed to a large number of manufacturers like Abbott, F. Hoffmann-La Roche Ltd, Bio-Rad Laboratories, Inc., and others and the higher adoption of kits in various research processes. The same segment is likely to register the highest CAGR in the during the forecast period. The kits segment is further sub-segmented into serological test kits, immunoglobulin kits, and lateral flow assay kits.

The global antibody testing market, based on indication is segmented into pregnancy, cardiovascular diseases, autoimmune diseases, infectious diseases, oncology, endocrine diseases, and others. The infectious diseases segment held the largest share of the market in 2021, and the same segment is anticipated to register the highest CAGR of 8.2% in the market during the forecast period. The infectious diseases segment is further sub-segmented into COVID-19, hepatitis, HIV, tuberculosis, influenza, human papillomavirus (HPV), and others. Endocrine diseases are further segmented into diabetes, thyroid disorders, and others. Oncology is further segmented into breast cancer, melanoma, gastric cancer, and others. Autoimmune diseases are further segmented into rheumatoid arthritis, inflammatory bowel disease, multiple sclerosis, and others.

Infectious Diseases are caused by microorganisms, such as bacteria, viruses, fungi, and parasites. A diagnostic test for an infectious agent is used to demonstrate the presence of infectious diseases. Specimens such as urine, blood, sputum, cerebrospinal fluid, and others are subjected to various tests, and the disease-causing bacteria and viruses, known as the infectious agents, are identified quickly. Early diagnosis and determining treatment orientation are important in medical practice. It is beneficial and helpful for providing information for diagnosis and treatment through real-time testing at the bedside.

Global antibody testing market, based on end user is segmented into hospitals, academic & research institutes, diagnostic laboratories, biopharmaceutical companies. The diagnostic laboratories segment held the largest share of the market in 2021, and same segment is anticipated to register the highest CAGR of 7.7% in the market during the forecast period.

Ever since severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was declared a public health emergency of international concern in late January 2020, medical professionals and researchers have been urging the need for comprehensive and rapid testing of citizens to plan measures that can contain the spread of the virus. Over time, real-time polymerase chain reaction tests and antibody tests have emerged as vital techniques for the global healthcare system to manage the outbreak. Antibody detection is essential for differential diagnosis of SARS-CoV-2. It is a test performed by patient serum or plasma with reagent red cells. Determination of specific antibodies to viral and bacterial pathogens and parasites facilitates the correct therapeutic measures to be taken. Antibody testing is critical for implementing an effective and efficient public health strategy to minimize the adverse impact of the COVID-19 pandemic. It should be adopted for important clinical utility cases and support return-to-work strategy globally.

COVID-19 pandemic has become the most significant challenge across the world. This challenge will be frightening especially in developing countries across the globe as it will lead to reducing imports due to disruptions in global trade. Till date no definitive treatment against COVID 19 has been established. Hence, lack of definitive therapy offers significant opportunities for global antibody testing market as US FDA has recently approved use of plasma therapy for critically ill COVID 19 patients. In long run global Antibody Testing market will have significant growth prospects as many market players has received emergency use authorization for their newly developed antibody tests. All such developments will add up to the future demand for antibody testing market.

Thermo Fisher Scientific; Abbott Laboratories; Bio-Rad Laboratories, Inc.; Beckton, Dickinson And Company; F. Hoffmann La Roche; Agilent Technologies; DiaSorin; Zeus Scientific; ABCAM; Trinity Biotech are among the leading companies operating in the antibody testing market.

Global Antibody Testing Market, by Region, 2021 (%)

---

Antibody Testing Market Size & Trends | Industry Analysis 2028

Download Free Sample

---

Antibody Testing Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Products (Kits, Chemical & reagents, and Consumables), Indication (Pregnancy, Cardiovascular Diseases, Autoimmune Diseases, Infectious Diseases, Oncology, Endocrine Diseases, and Others), End User (Hospitals, Academic and Research Institutes, Diagnostic Laboratories, and Biopharmaceutical Companies)

Geographically, the anal irrigation systems market has been segmented as follows:

By geography, the market is segmented into North America (the US, Canada, and Mexico), Europe (UK, Germany, France, Italy, Spain, Greece and the Rest of Europe), Asia Pacific (China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific), the Middle East & Africa (UAE, Saudi Arabia, Africa, and Rest of Middle East & Africa), and South and Central America (Brazil, Argentina, and the Rest of South and Central America).